| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 3.72% | UBS | $70 → $75 | Maintains | Neutral |
| 11/22/2023 | -5.96% | Morgan Stanley | $53 → $68 | Maintains | Equal-Weight |
| 11/22/2023 | 14.78% | Telsey Advisory Group | $74 → $83 | Maintains | Outperform |
| 11/21/2023 | 2.33% | Telsey Advisory Group | → $74 | Reiterates | Outperform → Outperform |
| 11/14/2023 | 2.33% | Telsey Advisory Group | $62 → $74 | Maintains | Outperform |
| 11/13/2023 | -3.2% | UBS | $53 → $70 | Maintains | Neutral |
| 09/07/2023 | -14.26% | Telsey Advisory Group | $56 → $62 | Maintains | Outperform |
| 08/25/2023 | -29.47% | Morgan Stanley | $18 → $51 | Upgrades | Underweight → Equal-Weight |
| 08/24/2023 | -14.26% | JP Morgan | $45 → $62 | Maintains | Neutral |
| 08/24/2023 | -26.71% | UBS | $42 → $53 | Maintains | Neutral |
| 08/24/2023 | -22.56% | Telsey Advisory Group | $47 → $56 | Maintains | Outperform |
| 08/23/2023 | -35% | Telsey Advisory Group | → $47 | Reiterates | Outperform → Outperform |
| 08/16/2023 | -35% | Telsey Advisory Group | $35 → $47 | Maintains | Outperform |
| 08/15/2023 | -37.77% | Citigroup | $33 → $45 | Maintains | Neutral |
| 06/12/2023 | -43.3% | Argus Research | → $41 | Upgrades | Hold → Buy |
| 05/25/2023 | -75.11% | Morgan Stanley | $17 → $18 | Maintains | Underweight |
| 05/25/2023 | -54.36% | Citigroup | $24 → $33 | Maintains | Neutral |
| 05/25/2023 | -55.75% | UBS | $28 → $32 | Maintains | Neutral |
| 05/25/2023 | -51.6% | Telsey Advisory Group | → $35 | Reiterates | Outperform → Outperform |
| 05/24/2023 | -51.6% | Telsey Advisory Group | → $35 | Reiterates | Outperform → Outperform |
| 05/18/2023 | -66.81% | Citigroup | $32 → $24 | Maintains | Neutral |
| 05/17/2023 | -51.6% | Telsey Advisory Group | → $35 | Reiterates | Outperform → Outperform |
| 05/09/2023 | -58.51% | Jefferies | $35 → $30 | Maintains | Buy |
| 04/12/2023 | — | Argus Research | Downgrades | Buy → Hold | |
| 03/29/2023 | -61.28% | UBS | $29 → $28 | Maintains | Neutral |
| 03/02/2023 | -55.75% | Citigroup | $33 → $32 | Maintains | Neutral |
| 03/02/2023 | -61.28% | JP Morgan | $31 → $28 | Maintains | Neutral |
| 03/02/2023 | -76.49% | Morgan Stanley | $16 → $17 | Maintains | Underweight |
| 03/02/2023 | -59.9% | UBS | $28 → $29 | Maintains | Neutral |
| 03/02/2023 | -51.6% | Telsey Advisory Group | $33 → $35 | Maintains | Outperform |
| 03/01/2023 | -54.36% | Telsey Advisory Group | → $33 | Reiterates | → Outperform |
| 02/23/2023 | -54.36% | Telsey Advisory Group | → $33 | Reiterates | → Outperform |
| 02/21/2023 | -54.36% | Citigroup | $30 → $33 | Maintains | Neutral |
| 01/23/2023 | -58.51% | JP Morgan | $26 → $30 | Maintains | Neutral |
| 01/10/2023 | -61.28% | UBS | $24 → $28 | Maintains | Neutral |
| 01/10/2023 | — | Morgan Stanley | Assumes | → Underweight | |
| 01/10/2023 | -54.36% | Telsey Advisory Group | $27 → $33 | Maintains | Outperform |
| 11/28/2022 | -77.87% | Morgan Stanley | $15 → $16 | Maintains | Underweight |
| 11/23/2022 | -68.19% | Citigroup | $19 → $23 | Maintains | Neutral |
| 11/23/2022 | -62.66% | Telsey Advisory Group | $25 → $27 | Maintains | Outperform |
| 10/31/2022 | -76.49% | JP Morgan | $20 → $17 | Maintains | Neutral |
| 08/31/2022 | -73.73% | Citigroup | $21 → $19 | Maintains | Neutral |
| 08/30/2022 | -79.26% | Morgan Stanley | $17 → $15 | Maintains | Underweight |
| 08/26/2022 | -65.43% | Telsey Advisory Group | $30 → $25 | Maintains | Outperform |
| 05/25/2022 | -51.6% | B. Riley Securities | $48 → $35 | Maintains | Buy |
| 05/25/2022 | -70.96% | UBS | $34 → $21 | Maintains | Neutral |
| 05/25/2022 | -76.49% | Morgan Stanley | $32 → $17 | Maintains | Underweight |
| 05/25/2022 | -58.51% | Telsey Advisory Group | $40 → $30 | Maintains | Outperform |
| 05/23/2022 | -58.51% | Citigroup | $59 → $30 | Downgrades | Buy → Neutral |
| 05/16/2022 | -46.07% | JP Morgan | $35 → $39 | Maintains | Neutral |
| 03/03/2022 | -44.68% | Telsey Advisory Group | $45 → $40 | Maintains | Outperform |
| 01/11/2022 | -37.77% | Telsey Advisory Group | $55 → $45 | Maintains | Outperform |
| 01/07/2022 | -48.83% | UBS | $68 → $37 | Downgrades | Buy → Neutral |
| 06/09/2021 | -21.18% | Jefferies | $46 → $57 | Upgrades | Hold → Buy |
| 06/08/2021 | -35% | Argus Research | → $47 | Upgrades | Hold → Buy |
| 06/04/2021 | -57.13% | Morgan Stanley | $22 → $31 | Maintains | Underweight |
| 05/27/2021 | -23.94% | Telsey Advisory Group | $48 → $55 | Maintains | Outperform |
| 05/19/2021 | -33.62% | Telsey Advisory Group | $32 → $48 | Maintains | Outperform |
| 04/07/2021 | — | UBS | Upgrades | Neutral → Buy | |
| 03/04/2021 | -69.58% | Morgan Stanley | $14 → $22 | Maintains | Underweight |
| 12/01/2020 | -80.64% | Morgan Stanley | $10 → $14 | Maintains | Underweight |
| 11/25/2020 | -75.11% | B of A Securities | $9 → $18 | Maintains | Underperform |
| 11/25/2020 | -70.96% | UBS | $18 → $21 | Maintains | Neutral |
| 08/31/2020 | -86.17% | Morgan Stanley | $8 → $10 | Maintains | Underweight |
| 08/28/2020 | -87.55% | B of A Securities | $8 → $9 | Maintains | Underperform |
| 08/12/2020 | -86.17% | UBS | → $10 | Initiates Coverage On | → Neutral |
| 04/21/2020 | -88.94% | Morgan Stanley | $13 → $8 | Maintains | Underweight |
| 04/14/2020 | -82.02% | B. Riley Securities | $11 → $13 | Maintains | Buy |
| 04/03/2020 | — | B. Riley Securities | Upgrades | Neutral → Buy | |
| 03/26/2020 | -83.41% | B. Riley Securities | $15 → $12 | Maintains | Neutral |
| 03/11/2020 | -77.87% | Wedbush | $14 → $16 | Upgrades | Neutral → Outperform |
| 01/14/2020 | -72.34% | Baird | $18 → $20 | Maintains | Neutral |
| 01/07/2020 | -75.11% | Wedbush | $16 → $18 | Maintains | Neutral |
| 09/18/2019 | -75.11% | DA Davidson | → $18 | Initiates Coverage On | → Neutral |
| 09/04/2019 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
| 09/03/2019 | -80.64% | Morgan Stanley | $15 → $14 | Maintains | Underweight |
| 08/30/2019 | -77.87% | Wedbush | $18 → $16 | Maintains | Neutral |
| 08/30/2019 | -76.49% | RBC Capital | $20 → $17 | Maintains | Sector Perform |
| 08/30/2019 | — | Deutsche Bank | Upgrades | Sell → Hold | |
| 07/11/2019 | -75.11% | Wedbush | $16 → $18 | Upgrades | Underperform → Neutral |
| 05/30/2019 | -77.87% | B of A Securities | $20 → $16 | Maintains | Underperform |
| 05/30/2019 | -77.87% | Wedbush | $23 → $16 | Maintains | Underperform |
| 05/09/2019 | — | Wedbush | Downgrades | Neutral → Underperform | |
| 03/07/2019 | -79.26% | Morgan Stanley | $14 → $15 | Maintains | Underweight |
| 03/07/2019 | -62.66% | JP Morgan | $19 → $27 | Upgrades | Underweight → Neutral |
| 11/30/2018 | -66.81% | RBC Capital | $23 → $24 | Maintains | Sector Perform |
What is the target price for Abercrombie & Fitch (ANF)?
The latest price target for Abercrombie & Fitch (NYSE: ANF) was reported by Morgan Stanley on November 22, 2023. The analyst firm set a price target for $68.00 expecting ANF to fall to within 12 months (a possible -5.96% downside). 39 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Abercrombie & Fitch (ANF)?
The latest analyst rating for Abercrombie & Fitch (NYSE: ANF) was provided by Morgan Stanley, and Abercrombie & Fitch maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Abercrombie & Fitch (ANF)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Abercrombie & Fitch, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Abercrombie & Fitch was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
Is the Analyst Rating Abercrombie & Fitch (ANF) correct?
While ratings are subjective and will change, the latest Abercrombie & Fitch (ANF) rating was a maintained with a price target of $53.00 to $68.00. The current price Abercrombie & Fitch (ANF) is trading at is $72.31, which is out of the analyst's predicted range.